查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1912817

無菌靜脈輸血管市場按產品類型、材質類型、管蓋類型、應用和最終用戶分類－2026-2032年全球預測

Sterile Venous Blood Collection Tube Market by Product Type, Material Type, Closure Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

無菌靜脈採血管市場預計到 2025 年將達到 17.4 億美元，到 2026 年將成長到 18.5 億美元，到 2032 年將達到 26 億美元，複合年成長率為 5.86%。

關鍵市場統計數據
基準年 2025 17.4億美元
預計年份：2026年 18.5億美元
預測年份 2032 26億美元
複合年成長率 (%) 5.86%

無菌靜脈採血管是現代臨床診斷的基本組成部分，直接影響檢測結果的可靠性以及病人和醫護人員的安全。隨著以樣本主導的醫療模式的擴展，這些關鍵耗材對下游分析流程至關重要，影響從血液檢測組合到複雜免疫分析的方方面面。在此背景下，製造商、臨床檢查室和採購團隊必須妥善管理，因為材料的選擇、管蓋的化學性質和操作規程與分析設備本身同樣重要。

從傳統的玻璃材質轉向工程塑膠系統和先進的密封材料，重塑了採購標準和工作流程。因此，臨床相關人員越來越需要能夠最佳化檢體穩定性、最大限度降低污染風險並支援高通量環境下自動化操作的儀器。同時，監管力度和品質保證要求也在不斷提高，迫使製造商加強對驗證數據的投入，並與最終用戶進行更緊密的合作。這些因素共同作用，使得產品改進能夠顯著提升診斷信心和檢查室效率，因此，研發、生產和供應鏈部門之間的策略合作對於保持競爭力至關重要。

變革性轉變正在重新定義無菌靜脈採血管的設計、自動化整合、材料選擇、管蓋演變、供應鏈韌性和永續性促進因素。

目前，無菌靜脈採血管產業正經歷多項變革，這些變革正在重新定義無菌靜脈採血管的設計、製造和應用方式。其中最顯著的是檢體採集和處理的自動化程度不斷提高。自動化採集裝置、條碼採血管以及與實驗室資訊系統的整合，減少了人工操作環節，並推動了對能夠在機械化工作流程中保持穩定性能的採血管的需求。同時，材料創新正推動採血管材料從傳統玻璃轉向工程塑膠的轉變，後者兼具耐用性、化學惰性和環境友善性。這種材料轉變與密封技術的進步相輔相成，塑性體、橡膠和矽膠等不同材質的密封材料被選用，以最佳化真空保持性、針頭相容性和污染控制。

分析2025年美國關稅對無菌靜脈採血管的採購、定價及跨境生產的累積影響

美國2025年實施的新關稅為無菌靜脈採血管的全球籌資策略帶來了新的複雜性。關稅調整改變了跨境生產的相對經濟效益，促使買賣雙方重新評估其供應商組合，並探索降低成本波動的替代方案。為此，採購團隊正致力於供應商多元化，盡可能將生產外包，並簽訂長期契約，以更清晰地了解到岸成本和交貨時間。這些策略性因應措施通常伴隨著營運方面的調整，例如增加關鍵SKU的庫存緩衝，並逐步擴大國內或區域產能。

基於細分市場的洞察揭示了產品類型、應用需求、最終用戶環境、材料選擇和封口方式選擇對產品設計和採購的影響。

細分市場分析提供針對性的洞察，為產品開發、採購和臨床實施決策提供資訊支援。按產品類型分類的市場分析涵蓋非真空採血管和真空採血管，此區分體現了不同的應用情境。真空採血管系統因其穩定的採血量和自動化功能，在標準化採血應用中佔據主導地位；而非真空採血管則更適用於需要手動注射器或特殊採血操作的場合。按應用領域分類，市場分析涵蓋臨床化學、凝血、血液學和免疫學四個細分領域。臨床化學進一步細分為電解質分析和酵素分析。凝血進一步細分為部份凝血活酵素時間和凝血酶原時間，血液學進一步細分為全血球計數和分類計數。免疫學領域進一步細分為流式細胞技術和血清學檢測。這些應用層面的差異會影響採血管添加劑的選擇、抗凝血劑類型以及檢體穩定性需求。這意味著產品系列必須根據其支援的特定分析工作流程進行客製化。

影響無菌採血管應用和監管的區域趨勢：美洲、歐洲/中東/非洲和亞太地區

區域趨勢塑造了需求模式、監管重點和供應策略，每種趨勢都需要不同的營運因應措施。在美洲，買家往往優先考慮採購效率、與高通量檢測系統的兼容性以及物流可靠性。這些優先事項轉化為對標準化產品的需求，這些產品能夠與現有自動化系統無縫整合，並提供可靠的供應保障。在歐洲、中東和非洲，不同的管理體制和醫療保健基礎設施造就了區域合規性、多樣化的分銷模式和靈活的包裝解決方案至關重要的市場。能夠提供清晰的監管文件和靈活配置的供應商更有可能在這些市場獲得青睞。在亞太地區，快速的產能擴張、強大的製造能力以及對成本競爭力解決方案的關注，與日益成長的品質期望和區域監管協調性要求相平衡，後者正在推動對生產規模和檢驗數據的投資。

無菌靜脈採血管領域主要企業的概況和競爭策略，包括創新路徑、夥伴關係和生產製造。

無菌靜脈採血管領域的企業發展趨勢反映了創新主導的差異化和規模化並存的特徵。主要企業始終專注於以下幾個方面：提供檢驗的材料和管蓋以滿足各種應用需求；維護經認證的品管系統；以及確保可追溯的供應鏈，以支援臨床和監管審核。許多企業與診斷設備製造商合作，以獲得相容性認證並簡化採購決策。其他企業則專注於專有的管蓋或賦形劑技術，以提高特定檢測方法的檢體穩定性。此外，競爭對手普遍對生產能力進行策略性投資，尤其是在能夠降低物流複雜性的地區。

為產業領導者提供切實可行的建議，以提高產品安全性、簡化採購流程、實現採購來源多元化並採用先進的封蓋技術。

產業領導者可以透過一系列切實可行的步驟，將市場動態轉化為競爭優勢。首先，優先考慮產品安全性和檢驗，投資於標準化的效能數據和終端用戶培訓，以減少分析前誤差並加速臨床應用。其次，透過提供可設定的供應合約、透明的前置作業時間和SKU合理化，簡化採購流程，幫助大型實驗室降低採購複雜性。第三，考慮採購多元化和地域性生產冗餘，以維持成本競爭力，同時降低關稅和物流中斷的風險。

調查方法：一手與二手資料、相關人員訪談、文件分析、嚴格的品質保證通訊協定

本報告的研究採用混合方法，結合了與相關人員的直接對話、嚴謹的二手資料研究和技術審查。一級資訊來源包括對臨床實驗室主任、採購人員、生產營運經理和法規事務專家的結構化訪談，從而獲得關於營運挑戰和決策標準的第一手資訊。二級資訊來源包括同行評審期刊文章、監管指導文件、標準參考資料以及醫療設備製造商發布的技術規範，用於提供背景資訊並檢驗訪談中發現的主題。在特定情況下，還審查了檢查室層面的性能數據和桌上型測試報告，以支援有關材料相容性、密封性能和檢體穩定性的論點。

這份概要將臨床需求、供應鏈現況、監管影響和創新需求整合到一個連貫的觀點中，供領導者參考。

這項綜合分析匯集了臨床需求、材料科學、封口技術、供應鏈現狀以及區域監管差異，從而全面展現了無菌靜脈採血管的現狀。諸如檢體完整性和感染預防等臨床需求持續驅動著產品預期，而自動化相容性和採購便利性等營運因素則決定買家的選擇。同時，材料和封口裝置的創新為解決以往難以解決的難題（例如檢體穩定性以及與各種檢測方法的兼容性）創造了機會。此外，監管審查力度加大、永續性勢在必行以及貿易政策的轉變等外部因素正在重塑供應商的策略和採購行為。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 無菌靜脈採血管市場（依產品類型分類）

  • 非真空管
  • 真空採血管

9. 依材料類型分類的無菌靜脈採血管市場

  • 玻璃
  • 塑膠

第10章 無菌靜脈採血管市場按類型分類的關閉情況

  • 塑性體
  • 橡皮
  • 矽酮

第11章 無菌靜脈採血管市場依應用領域分類

  • 臨床化學
    • 電解質分析
    • 酶學測量
  • 凝血
    • 部份凝血活酵素時間
    • 凝血酶原時間
  • 血液學
    • 血液常規檢查
    • 白血球分類
  • 免疫學
    • 流式細胞技術
    • 血清學檢測

第12章 依最終用戶分類的無菌靜脈輸血管市場

  • 門診治療中心
    • 門診護理設施
    • 醫生辦公室檢查室
  • 血庫
    • 私人血庫
    • 公共血庫
  • 診斷檢查室
    • 臨床檢查室
    • 獨立檢驗機構
  • 醫院檢查室
    • 私立醫院
    • 公立醫院

13. 按地區分類的無菌靜脈輸血管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的無菌靜脈輸血管市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國無菌靜脈輸血管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國無菌靜脈輸血管市場

第17章 中國無菌靜脈輸血管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • CML Biotech（P）Ltd.
  • DWK Life Sciences（Wheaton）
  • FL Medical Srl
  • Greiner Bio-One International GmbH
  • Hindustan Syringes & Medical Devices Ltd
  • Medtronic plc
  • Narang Medical Limited
  • Nipro Medical Corporation
  • QIAGEN NV
  • Sarstedt AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13AB8

The Sterile Venous Blood Collection Tube Market was valued at USD 1.74 billion in 2025 and is projected to grow to USD 1.85 billion in 2026, with a CAGR of 5.86%, reaching USD 2.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.74 billion
Estimated Year [2026] USD 1.85 billion
Forecast Year [2032] USD 2.60 billion
CAGR (%) 5.86%

Sterile venous blood collection tubes are a foundational element of modern clinical diagnostics, directly influencing the integrity of laboratory results and the safety of both patients and healthcare personnel. As sample-driven medicine expands, these primary consumables remain critical to downstream analytics, affecting everything from hematology panels to complex immunology assays. In this context, manufacturers, clinical laboratories, and procurement teams must navigate a landscape where material selection, closure chemistry, and handling protocols are as consequential as analytical instrumentation.

Transitioning from historical glass-based approaches to engineered plastic systems and advanced closure materials has reshaped procurement criteria and operational workflows. Consequently, clinical stakeholders increasingly demand devices that optimize sample stability, minimize contamination risk, and support automation across high-throughput environments. At the same time, regulatory scrutiny and quality assurance expectations have intensified, prompting manufacturers to invest in validation data and to engage more closely with end users. Taken together, these forces create an environment where incremental product improvements can yield outsized benefits in diagnostic confidence and laboratory efficiency, and where strategic alignment across R&D, manufacturing, and supply chain functions is essential for sustained relevance.

Transformative shifts redefining sterile venous blood collection tube design, automation integration, material choices, closure evolution, supply chain resilience, and sustainability drivers

The industry is undergoing several transformative shifts that are redefining how sterile venous blood collection tubes are designed, produced, and deployed. Foremost among these is the acceleration of automation in sample collection and handling; automated phlebotomy adjuncts, barcoded tubes, and integration with laboratory information systems are reducing manual touchpoints and driving demand for tubes that deliver consistent performance in mechanized workflows. Concurrently, material innovation is moving the sector away from legacy glass toward engineered plastics that balance durability, chemical inertness, and environmental considerations. These material transitions also interact with closure technology evolution, where plastomer, rubber, and silicone variants are selected to optimize vacuum retention, needle compatibility, and contamination control.

In parallel, heightened focus on infection prevention and sample integrity is prompting more rigorous validation protocols and supplier transparency. Supply chains are becoming more resilient through regionalization and strategic stock positioning, which influences sourcing strategies and lead-time expectations. Environmental sustainability considerations, such as recyclable components and reduced packaging, are emerging as differentiators for purchasers, while digital traceability is becoming a valued capability for clinical risk management. These cumulative shifts are altering stakeholder expectations and creating new decision criteria that extend beyond unit price to encompass lifecycle performance and systems compatibility.

Analyzing the cumulative impact of United States tariffs in 2025 on sterile venous blood collection tube sourcing, pricing dynamics, and cross-border manufacturing

The introduction of new tariff measures in the United States in 2025 has introduced fresh complexity into global sourcing and procurement strategies for sterile venous blood collection tubes. Tariff adjustments alter the relative economics of cross-border manufacturing, prompting both buyers and suppliers to reassess supplier portfolios and to explore alternatives that mitigate cost volatility. In response, procurement teams are emphasizing supplier diversification, nearshoring where feasible, and longer-term contractual arrangements that provide greater clarity on landed cost and delivery timing. These strategic responses are often paired with operational changes, such as higher inventory buffers for critical SKUs and staged ramp-ups of domestic or regional production capabilities.

Manufacturers facing tariff-driven input cost pressures may prioritize efficiency gains in production, negotiate alternative raw material sources, or accelerate investments in regional manufacturing footprints. For clinical users, transitional procurement practices and collaborative supplier agreements can help preserve continuity of supply and reduce the administrative burden associated with sudden contract renegotiations. Importantly, organizations are also reassessing the resilience of extended supply chains and the trade-offs between short-term pricing benefits and long-term supply certainty. As a result, tariff dynamics act as a catalyst for strategic realignment across sourcing, manufacturing planning, and cross-border logistics, with implications for both operational reliability and product innovation timelines.

Segmentation-driven insights revealing how product type, application requirements, end user environments, material choices, and closure selections influence product design and procurement

Segmentation analysis yields targeted insights that inform product development, procurement, and clinical deployment decisions. Based on Product Type, market is studied across Non Vacuum Tube and Vacuum Tube, and this distinction drives divergent use cases: tubes without vacuum tend to be favored where manual syringes or special collection procedures are used, while vacuum systems dominate standardized phlebotomy because they support consistent draw volumes and automation compatibility. Based on Application, market is studied across Clinical Chemistry, Coagulation, Hematology, and Immunology. The Clinical Chemistry is further studied across Electrolyte Analysis and Enzymatic Assays. The Coagulation is further studied across Partial Thromboplastin Time and Prothrombin Time. The Hematology is further studied across Complete Blood Count and White Blood Cell Differential. The Immunology is further studied across Flow Cytometry and Serology Testing. These application-level differences influence tube additive selection, anticoagulant types, and sample stability requirements, meaning that product portfolios must be tailored to the specific analytical workflows they will support.

Based on End User, market is studied across Ambulatory Care Centers, Blood Banks, Diagnostic Laboratories, and Hospital Laboratories. The Ambulatory Care Centers is further studied across Outpatient Facility and Physician Office Laboratory. The Blood Banks is further studied across Private Bank and Public Bank. The Diagnostic Laboratories is further studied across Clinical Laboratory and Independent Laboratory. The Hospital Laboratories is further studied across Private Hospital and Public Hospital. Each end user category imposes distinct procurement cycles, storage capacities, and quality expectations; for example, high-volume diagnostic laboratories prioritize tube compatibility with automated analyzers, while blood banks prioritize long-term storage stability and bag compatibility. Based on Material Type, market is studied across Glass and Plastic, which presents trade-offs between chemical inertness and breakage risk, while Based on Closure Type, market is studied across Plastomer, Rubber, and Silicone, each offering different sealing performance, needle penetration characteristics, and compatibility with sterilization processes. Taken together, these segmentation layers form a multidimensional set of decision criteria that manufacturers and purchasers must align with clinical protocols and operational constraints.

Regional dynamics shaping sterile venous blood collection tube adoption and regulation across Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape demand patterns, regulatory focus, and supply strategies in ways that require distinct operational responses. In the Americas, buyers often emphasize procurement efficiency, compatibility with high-throughput laboratory systems, and logistical reliability; these priorities lead to demand for standardized products that integrate seamlessly with existing automation while offering dependable supply assurances. In Europe, Middle East & Africa, heterogeneous regulatory regimes and varied healthcare infrastructures create a market where localized compliance, diverse distribution models, and flexible packaging solutions matter; suppliers that provide clear regulatory documentation and adaptable configurations tend to gain traction in these markets. In Asia-Pacific, rapid capacity expansion, strong manufacturing capabilities, and a focus on cost-competitive solutions are balanced against rising expectations for quality and local regulatory harmonization, which drives investment in both manufacturing scale and validation data.

Across regions, distribution models, import regulations, and reimbursement practices shape buyer behavior. Consequently, suppliers pursuing international expansion must tailor value propositions to regional priorities, aligning product specifications, quality documentation, and inventory strategies with the nuances of each geography. Strategic partnerships with regional distributors, investments in local quality systems, and modular product platforms that can be configured for diverse regulatory requirements are effective approaches to managing geographic complexity and capturing regional opportunities.

Profiles of leading companies and competitive strategies in sterile venous blood collection tubes including innovation pathways, partnerships, and manufacturing

Company-level dynamics in the sterile venous blood collection tube space reflect a blend of innovation-driven differentiation and operational scale. Leading manufacturers focus on a few consistent priorities: delivering validated materials and closures that meet diverse application needs, maintaining certified quality management systems, and ensuring traceable supply chains that support clinical and regulatory scrutiny. Many companies pursue partnerships with diagnostic instrument providers to certify compatibility and to simplify buyer decisions, while others emphasize proprietary closure or additive technologies that enhance sample stability for targeted assays. Strategic investments in manufacturing capacity, particularly in regions that reduce logistical complexity, are also common among competitive players.

In addition to product innovation, successful companies often leverage service-oriented capabilities such as technical support for clinical validation, training for phlebotomy best practices, and documentation that eases regulatory submissions. Collaboration with third-party laboratories for analytical validation and with clinical networks for real-world performance feedback accelerates product acceptance. Firms that balance rigorous quality control, clear documentation, and proactive customer engagement create defensible advantages and foster deeper buyer trust, which becomes particularly important in procurement scenarios that value reliability and long-term supply commitments.

Actionable recommendations for industry leaders to enhance product safety, streamline procurement, diversify sourcing, and adopt advanced closure technologies

Industry leaders can translate market dynamics into competitive advantage through a set of pragmatic, actionable measures. First, prioritize product safety and validation by investing in standardized performance data and end user training to reduce pre-analytical error and to accelerate clinical adoption. Second, streamline procurement by offering configurable supply agreements, transparent lead-time commitments, and SKU rationalization that helps large laboratories reduce procurement complexity. Third, diversify sourcing and consider geographic production redundancy to mitigate tariff and logistics disruption risks while preserving cost competitiveness.

Fourth, accelerate adoption of advanced closure and material technologies that improve sample stability and compatibility with automation, and support these launches with rigorous comparative data and third-party validations. Fifth, deepen collaboration with diagnostic instrument vendors and clinical laboratories to certify interoperability and to co-develop bundled solutions that simplify buyer decision-making. Sixth, incorporate sustainability objectives into product design and packaging to align with institutional environmental goals and procurement policies. Finally, maintain active regulatory engagement and robust quality systems to expedite approvals and to provide buyers with the documentation needed for clinical and purchasing committees. These measures collectively translate strategy into operational steps that improve resilience, reduce clinical risk, and enhance commercial traction.

Research methodology outlining primary and secondary sources, stakeholder interviews, material analysis, and rigorous quality assurance protocols

The research underpinning this report uses a mixed-methods approach that combines primary stakeholder engagement with rigorous secondary analysis and technical review. Primary inputs include structured interviews with clinical laboratory directors, procurement leads, manufacturing operations managers, and regulatory affairs specialists, which provide firsthand insights into operational challenges and decision criteria. Secondary inputs encompass peer-reviewed publications, regulatory guidance documents, standards references, and publicly available technical specifications from device manufacturers; these sources inform context and validate themes identified in interviews. In selected instances, laboratory-level performance data and bench testing reports are reviewed to corroborate claims about material compatibility, closure performance, and sample stability.

To ensure reliability, findings are triangulated across multiple sources and subjected to internal quality assurance protocols, including cross-validation of interview themes, consistency checks against technical documentation, and review by subject matter experts with clinical and manufacturing experience. The methodology emphasizes transparency about data provenance, explicitly documenting assumptions and limitations where direct comparative data are limited. Together, these elements provide a robust foundation for the conclusions and recommendations presented, while acknowledging the need for ongoing validation as technologies and regulatory conditions evolve.

Concluding synthesis that ties clinical needs, supply chain realities, regulatory influences, and innovation imperatives into a coherent perspective for leaders

The synthesis draws together clinical requirements, material science, closure technology, supply chain realities, and regional regulatory differences to present an integrated view of the sterile venous blood collection tube landscape. Clinical imperatives such as sample integrity and infection prevention continue to drive product expectations, while operational factors like automation compatibility and procurement simplicity determine buyer choices. Concurrently, material and closure innovations are creating opportunities to address historically persistent challenges, including sample stability and compatibility with diverse assays. At the same time, external forces-regulatory scrutiny, sustainability imperatives, and trade policy shifts-are reshaping supplier strategies and procurement behavior.

For decision-makers, the implication is clear: success depends on aligning product design and validation with end user workflows, constructing resilient and diversified supply chains, and engaging proactively with regulatory bodies and clinical partners. Organizations that integrate these elements into coherent strategies will be better positioned to manage disruption, to deliver predictable clinical outcomes, and to create enduring differentiation in an increasingly quality-driven and efficiency-focused environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sterile Venous Blood Collection Tube Market, by Product Type

  • 8.1. Non Vacuum Tube
  • 8.2. Vacuum Tube

9. Sterile Venous Blood Collection Tube Market, by Material Type

  • 9.1. Glass
  • 9.2. Plastic

10. Sterile Venous Blood Collection Tube Market, by Closure Type

  • 10.1. Plastomer
  • 10.2. Rubber
  • 10.3. Silicone

11. Sterile Venous Blood Collection Tube Market, by Application

  • 11.1. Clinical Chemistry
    • 11.1.1. Electrolyte Analysis
    • 11.1.2. Enzymatic Assays
  • 11.2. Coagulation
    • 11.2.1. Partial Thromboplastin Time
    • 11.2.2. Prothrombin Time
  • 11.3. Hematology
    • 11.3.1. Complete Blood Count
    • 11.3.2. White Blood Cell Differential
  • 11.4. Immunology
    • 11.4.1. Flow Cytometry
    • 11.4.2. Serology Testing

12. Sterile Venous Blood Collection Tube Market, by End User

  • 12.1. Ambulatory Care Centers
    • 12.1.1. Outpatient Facility
    • 12.1.2. Physician Office Laboratory
  • 12.2. Blood Banks
    • 12.2.1. Private Bank
    • 12.2.2. Public Bank
  • 12.3. Diagnostic Laboratories
    • 12.3.1. Clinical Laboratory
    • 12.3.2. Independent Laboratory
  • 12.4. Hospital Laboratories
    • 12.4.1. Private Hospital
    • 12.4.2. Public Hospital

13. Sterile Venous Blood Collection Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sterile Venous Blood Collection Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sterile Venous Blood Collection Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Sterile Venous Blood Collection Tube Market

17. China Sterile Venous Blood Collection Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AdvaCare Pharma
  • 18.6. Becton, Dickinson and Company
  • 18.7. Cardinal Health, Inc.
  • 18.8. CML Biotech (P) Ltd.
  • 18.9. DWK Life Sciences (Wheaton)
  • 18.10. F.L. Medical Srl
  • 18.11. Greiner Bio-One International GmbH
  • 18.12. Hindustan Syringes & Medical Devices Ltd
  • 18.13. Medtronic plc
  • 18.14. Narang Medical Limited
  • 18.15. Nipro Medical Corporation
  • 18.16. QIAGEN N.V.
  • 18.17. Sarstedt AG & Co. KG
  • 18.18. Sekisui Medical Co., Ltd.
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY NON VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY NON VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY NON VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY RUBBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY RUBBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY ELECTROLYTE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY ELECTROLYTE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY ELECTROLYTE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY ENZYMATIC ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY ENZYMATIC ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY ENZYMATIC ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PARTIAL THROMBOPLASTIN TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PROTHROMBIN TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PROTHROMBIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COMPLETE BLOOD COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COMPLETE BLOOD COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY WHITE BLOOD CELL DIFFERENTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY WHITE BLOOD CELL DIFFERENTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY WHITE BLOOD CELL DIFFERENTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SEROLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY OUTPATIENT FACILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY OUTPATIENT FACILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY OUTPATIENT FACILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PHYSICIAN OFFICE LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PHYSICIAN OFFICE LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PHYSICIAN OFFICE LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE BANK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE BANK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE BANK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC BANK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC BANK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC BANK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY INDEPENDENT LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY INDEPENDENT LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY INDEPENDENT LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 236. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COAGULATION, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 278. G7 STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. G7 STERILE VENOUS BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)

TABLE 28